PDT Partners’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Sell |
91,869
-42,196
| -31% | -$143K | 0.02% | 590 |
|
|
2025
Q1 | $538K | Buy |
+134,065
| New | +$538K | 0.04% | 517 |
|
|
2023
Q3 | – | Sell |
-115,545
| Closed | -$987K | – | 605 |
|
|
2023
Q2 | $987K | Buy |
115,545
+34,254
| +42% | +$293K | 0.14% | 253 |
|
|
2023
Q1 | $747K | Buy |
81,291
+49,910
| +159% | +$459K | 0.1% | 323 |
|
|
2022
Q4 | $320K | Sell |
31,381
-55
| -0.2% | -$562 | 0.05% | 472 |
|
|
2022
Q3 | $463K | Sell |
31,436
-14,732
| -32% | -$217K | 0.07% | 455 |
|
|
2022
Q2 | $495K | Buy |
46,168
+26,733
| +138% | +$287K | 0.04% | 605 |
|
|
2022
Q1 | $210K | Buy |
+19,435
| New | +$210K | 0.02% | 807 |
|